Rational design of solution additives for the prevention of protein aggregation
about
Recent applications of Kirkwood-Buff theory to biological systemsCrowding Induced Entropy-Enthalpy Compensation in Protein Association EquilibriaCrystal structures of TM0549 and NE1324--two orthologs of E. coli AHAS isozyme III small regulatory subunit.Effects of solute-solute interactions on protein stability studied using various counterions and dendrimersL-arginine hydrochloride increases the solubility of folded and unfolded recombinant plasminogen activator rPA.Inhibition of protein aggregation: supramolecular assemblies of arginine hold the keyArginine and the Hofmeister Series: the role of ion-ion interactions in protein aggregation suppression.The effects of N-ethyl-N'-methyl imidazolium chloride on the solubility, stability and aggregation of tc-rPA.Space in systems biology of signaling pathways--towards intracellular molecular crowding in silico.Investigation of cosolute-protein preferential interaction coefficients: new insight into the mechanism by which arginine inhibits aggregation.Ion-specific effects on prion nucleation and strain formation.Biopharmaceutical formulations for pre-filled delivery devices.A multiscale view of therapeutic protein aggregation: a colloid science perspective.Preferential interactions of trehalose, L-arginine.HCl and sodium chloride with therapeutically relevant IgG1 monoclonal antibodies.A change in the aggregation pathway of bovine serum albumin in the presence of arginine and its derivatives.Effect of arginine on pre-nucleus stage of interferon beta-1b aggregationGlycation of Liver Cystatin: Implication on its Structure and Function.Effects of solutes on solubilization and refolding of proteins from inclusion bodies with high hydrostatic pressure.Predictive tools for stabilization of therapeutic proteins.Efficient refolding of aggregation-prone citrate synthase by polyol osmolytes: how well are protein folding and stability aspects coupled?The use of dynamic light scattering and brownian microscopy to characterize protein aggregation.Temperature denaturation and aggregation of a multi-domain protein (IgG1) investigated with an array of complementary biophysical methods.Retracted: Molecular characterization of excipients' preferential interactions with therapeutic monoclonal antibodies.Comparative thermal inactivation analysis of Aspergillus oryzae and Thiellavia terrestris cutinase: Role of glycosylation.Effect of compatible and noncompatible osmolytes on the enzymatic activity and thermal stability of bovine liver catalase
P2860
Q24653308-0206DDFD-F8DA-4D9B-BE10-141F8DD279AFQ27449513-28771CED-EFA1-4A50-BCD7-77BEFAB61AA9Q27646329-452B863F-81F7-4AB6-BE3F-B91661F135F9Q28478083-967499B3-936A-47EC-A1D0-F1C1066C161CQ30318611-D116B5DE-8013-4D64-8A60-4553BCB4D35FQ33305439-AE9D3FB2-DCB5-458E-98F0-5991BE997A12Q35033038-67522B8D-C587-464C-A51D-19B3E6C77DEBQ35088874-2D54735A-A4B3-4C0A-9C87-FA900861F92CQ36069196-CE147074-05E9-47B0-92EE-58A1BFDC1B62Q37190044-6337F90C-4E7B-4F72-9918-A09E497A638EQ37234018-F857D1EF-791F-4A37-8244-C3DE4A497A57Q38090687-3A2ADC71-E59B-4A40-A339-AB7E461023E4Q38378651-E45207D1-0EE0-4114-A7DD-9D76588D842CQ38652096-39760793-6169-4A06-B25D-2785E1AD0C52Q38714910-C0FEDE5D-C95A-42D8-9410-F21713887BBAQ38964177-B4823679-9F71-487A-9900-19C289AEA4F8Q39649360-16BDF747-89C2-4462-B8FE-41808E73CEB2Q41961798-68737B4A-4CFC-4DBF-9A4C-47BB424EA600Q42156173-C15CC356-C619-4703-B0E2-19661E32B41CQ45253855-50B9AFFE-652E-4259-944A-05705E59144CQ45649060-CB51DB92-52B0-445C-98A1-EC7BF87FC878Q46870536-FD0FB408-D8D9-4973-B071-BAC2B7A11D4DQ47834868-ECCB77FB-6E2F-46A7-8106-966AFC8B134AQ51245661-644BC822-EA6F-4E6B-9F05-A499B0147BD0Q57691292-3C33676F-434C-44A3-9D37-CEF39B6182D7
P2860
Rational design of solution additives for the prevention of protein aggregation
description
2004 nî lūn-bûn
@nan
2004 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Rational design of solution additives for the prevention of protein aggregation
@ast
Rational design of solution additives for the prevention of protein aggregation
@en
Rational design of solution additives for the prevention of protein aggregation
@nl
type
label
Rational design of solution additives for the prevention of protein aggregation
@ast
Rational design of solution additives for the prevention of protein aggregation
@en
Rational design of solution additives for the prevention of protein aggregation
@nl
prefLabel
Rational design of solution additives for the prevention of protein aggregation
@ast
Rational design of solution additives for the prevention of protein aggregation
@en
Rational design of solution additives for the prevention of protein aggregation
@nl
P2860
P1433
P1476
Rational design of solution additives for the prevention of protein aggregation
@en
P2093
Bernhardt L Trout
Brian M Baynes
P2860
P304
P356
10.1529/BIOPHYSJ.104.042473
P407
P577
2004-09-01T00:00:00Z